日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Model-Informed Drug Development for Ligelizumab in Patients With Chronic Spontaneous Urticaria

基于模型指导的利格利珠单抗治疗慢性自发性荨麻疹患者的药物开发

Bienczak, Andrzej; Gautier, Aurelie; Hua, Eva; Ji, Yan; Scosyrev, Emil; Smeets, Serge; Severin, Thomas; Drollmann, Anton; Patekar, Manmath; Savelieva, Marina

International Country-Level Trends, Factors, and Disparities in Compassionate Use Access to Unlicensed Products for Patients With Serious Medical Conditions

国际层面上,严重疾病患者获得未经许可产品的同情用药趋势、影响因素和差异

Aliu, Paul; Sarp, Séverine; Reichenbach, Ramona; Behr, Sigrid; Fitzsimmons, Paige; Shamlajee, Mansurahmad; Kola, Surya Prakash; Nunes Radimerski, Samantha; Scosyrev, Emil

A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combination Treatment for Asthma

对茚达特罗醋酸盐/格隆溴铵/糠酸莫米松独特药物研发策略的回顾:一种首创的、每日一次、单吸入器、固定剂量复方哮喘治疗药物

Brittain, Dominic; D'Andrea, Peter; Gruen, Emilie; Hosoe, Motoi; Jain, Devendra; Jauernig, Juergen; Pethe, Abhijit; Scosyrev, Emil; Tanase, Ana-Maria; Tillmann, Hanns-Christian

Medical Careers and Motherhood: A Cross-Sectional Study of Hispanic Female Physicians

医疗职业与母亲身份:一项针对西班牙裔女医生的横断面研究

Lopez-Leon, Sandra; Del Valle, Cipatli Ayuzo; Salceda, Alejandra Huante; Villegas-Pichardo, Luz Odette; Scosyrev, Emil

Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710)

混合组织学特征是否会影响局部晚期膀胱癌患者接受新辅助铂类联合化疗的生存获益?西南肿瘤协作组指导的跨组研究(S8710)的二次分析

Scosyrev, Emil; Ely, Benjamin W; Messing, Edward M; Speights, V O; Grossman, H Barton; Wood, David P; de Vere White, Ralph W; Vogelzang, Nicholas J; Trump, Donald L; Natale, Ronald B; Tangen, Catherine M; Crawford, E David; Thompson, Ian M